Using multicriteria decision analysis during drug development to predict reimbursement decisions

BACKGROUND: Pharmaceutical companies design clinical development programs to generate the data that they believe will support reimbursement for the experimental compound. OBJECTIVE: The objective of the study was to present a process for using multicriteria decision analysis (MCDA) by a pharmaceutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Paul, Mauskopf, Josephine, Lebiecki, Jake, Kilburg, Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Routledge 2014
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956287/
https://www.ncbi.nlm.nih.gov/pubmed/29785248
http://dx.doi.org/10.3402/jmahp.v2.25270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956287/
https://www.ncbi.nlm.nih.gov/pubmed/29785248
http://dx.doi.org/10.3402/jmahp.v2.25270

Ejemplares similares